Year : 2021  |  Volume : 23  |  Issue : 4  |  Page : 348-356

Testosterone, cardiomyopathies, and heart failure: a narrative review

1 Department of Cardiology, University of Medicine and Pharmacy, Craiova 200349, Romania
2 Department of Physiology, University of Medicine and Pharmacy, Craiova 200349, Romania

Correspondence Address:
Ionuţ Donoiu
Department of Cardiology, University of Medicine and Pharmacy, Craiova 200349
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/aja.aja_80_20

Rights and Permissions

Testosterone exerts an important regulation of cardiovascular function through genomic and nongenomic pathways. It produces several changes in cardiomyocytes, the main actor of cardiomyopathies, which are characterized by pathological remodeling, eventually leading to heart failure. Testosterone is involved in contractility, in the energy metabolism of myocardial cells, apoptosis, and the remodeling process. In myocarditis, testosterone directly promotes the type of inflammation that leads to fibrosis, and influences viremia with virus localization. At the same time, testosterone exerts cardioprotective effects that have been observed in different studies. There is increasing evidence that low endogenous levels of testosterone have a negative impact in some cardiomyopathies and a protective impact in others. This review focuses on the interrelationships between testosterone and cardiomyopathies and heart failure.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded177    
    Comments [Add]    
    Cited by others 1    

Recommend this journal